These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2933563)

  • 21. Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin.
    Basso G; Putti MC; Catoretti G; Consolini R; Galdiolo D; Guglielmi C; Messina C; Milanesi C; Testi AM; Xillo MZ
    Eur J Haematol; 1987 Feb; 38(2):111-6. PubMed ID: 3036570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terminal deoxynucleotidyl transferase-positive acute myeloblastic leukemia.
    McGraw TP; Folds JD; Bollum FJ; Stass SA
    Am J Hematol; 1981; 10(3):251-8. PubMed ID: 6264782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute leukaemia with mixed lymphoid and myeloid phenotype.
    Pui CH; Dahl GV; Melvin S; Williams DL; Peiper S; Mirro J; Murphy SB; Stass S
    Br J Haematol; 1984 Jan; 56(1):121-30. PubMed ID: 6584167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terminal deoxynucleotidyl transferase and HLA-DR expression appear unrelated to prognosis of acute myeloid leukaemia.
    Swirsky DM; Greaves MF; Gray RG; Rees JK
    Br J Haematol; 1988 Oct; 70(2):193-8. PubMed ID: 2973345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation of normal and malignant human immature lymphoid cells.
    Campana D; Janossy G
    Blood; 1988 May; 71(5):1201-10. PubMed ID: 3162813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens.
    Ryan D; Kossover S; Mitchell S; Frantz C; Hennessy L; Cohen H
    Blood; 1986 Aug; 68(2):417-25. PubMed ID: 2942198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of ultrastructural peroxidases and immunologic membrane markers in the diagnosis of acute leukemias.
    Marie JP; Perrot JY; Boucheix C; Zittoun J; Martyre MC; Kayibanda M; Rosenfeld C; Mishal Z; Zittoun R
    Blood; 1982 Feb; 59(2):270-6. PubMed ID: 6948582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
    Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
    Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blasts.
    Ha K; Freedman MH; Hrincu A; Petsche D; Poon A; Gelfand EW
    Blood; 1985 Dec; 66(6):1404-8. PubMed ID: 2415187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies.
    Imamura N; Kuramoto A
    Am J Hematol; 1991 Dec; 38(4):332-4. PubMed ID: 1836104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of TdT positivity in cases of leukemia and lymphoma.
    Drexler HG; Menon M; Minowada J
    Acta Haematol; 1986; 75(1):12-7. PubMed ID: 3088880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminal transferase in leukemias by flow cytometry.
    Loftin KC; Reuben JM; Dalton W; Hersh EM; Sujansky D
    Diagn Immunol; 1986; 4(3):165-9. PubMed ID: 3460728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal changes in childhood acute lymphoblastic leukemia: correlation with the presence of the cALL antigen.
    Rajantie J; Andersson LC; Siimes MA
    Leuk Res; 1984; 8(6):1103-5. PubMed ID: 6239955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
    Komada Y; Azuma E; Tanaka S; Ochiai H; Sakurai M
    Scand J Haematol; 1986 Jan; 36(1):85-91. PubMed ID: 2937137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
    Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
    Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cells.
    Campagnari F; Bombardieri E; de Braud F; Baldini L; Maiolo AT
    Int J Biol Markers; 1987; 2(1):31-42. PubMed ID: 3323341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic conversion of TdT+ adult AML to CALLA+ ALL.
    Marcus RE; Matutes E; Drysdale H; Catovsky D
    Scand J Haematol; 1985 Sep; 35(3):343-7. PubMed ID: 3864234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.